NICOLE TARDIO: Open Payments
NPI 1679742415 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 43 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $160 |
| Organon LLC | 8 | $134 |
| Galderma Laboratories, L.P. | 4 | $73 |
| Incyte Corporation | 3 | $54 |
| Botanix SB Inc | 3 | $54 |
| UCB, Inc. | 1 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $21 |
Products named: SKYRIZI, NEMLUVIO, VTAMA, OPZELURA, SOFDRA, Bimzelx, RINVOQ, Cabtreo.
Industry payments across NY — which companies pay providers there.
